Institutional Sign In

Go

GlaxoSmithKline Czech Republic - Gross Profit

GlaxoSmithKline CR`s Gross Profit reached 335 CZK mil in 2017. This is 12.7 % less than in the previous year.

$1.99

Buy Gross Profit data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic CZK mil ... ... ... ... ...             177 154 159 169 159    
Bayer Czech Republic CZK mil ... ... ...                 1.69 372 451 499 592    
GlaxoSmithKline Czech Republic CZK mil ... ... ...                 622 710 653 596 497    
Merck Czech Republic CZK mil ... ...                   232 230 184 201 263    
Novartis Czech Republic CZK mil                       405 435 500 710 776    
Pfizer Czech Republic CZK mil ... ...                   755 287 502 475 311    
Roche Czech Republic CZK mil ... ... ...                 620 634 770 763 1,489   ...
Sanofi-Aventis Czech Republic CZK mil ... ... ... ...               536 574 605 485 693    
Servier Czech Republic CZK mil ... ... ... ... ... ... ... ... ... ... ... ... 183 164 190 199    
Walmark CZK mil ... ... ...                 1,550 1,503 1,335 1,665 196